Category: News


A Note on COVID-19/Novel Coronavirus

Our thoughts are with everyone in The Mark Foundation community during this challenging and uncertain time. We at The Mark Foundation are staying abreast of the news and developments worldwide as well as within the scientific community. We understand that, in almost all cases, the response among our scientific partners involves taking swift action to … Continued

Partnership with Chordoma Foundation Announced to Fund Open-Source Research to Accelerate Drug Discovery

NEW YORK, NY – The Chordoma Foundation (CF) and The Mark Foundation for Cancer Research (MFCR) announced today a two-year, $1.4M partnership with a team of researchers at three institutions to develop new treatments for chordoma, a rare and difficult-to-treat bone cancer. The researchers will focus on creating the first drugs to inhibit a protein … Continued

New Cancer Center Established at Johns Hopkins University

With $5 million award, The Mark Foundation for Cancer Research partners with multi-investigator team at Johns Hopkins University developing next-generation genomics and imaging platforms for cancer immunotherapy NEW YORK, NY — The Mark Foundation for Cancer Research announced today the creation of The Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins … Continued

2020 Emerging Leader Awards Announced

$4.5 million awarded to six outstanding early career scientists to support innovation in cancer research The Mark Foundation for Cancer Research (MFCR) has awarded six grants to promising early career scientists for projects aimed at addressing unmet needs in cancer research. The Emerging Leader Award program aims to empower early career investigators to take on … Continued

$2.5 Million to JAX for Breakthrough Cancer Immunotherapy Project

$2.3M over five years

Four Projects Funded That Will Pave the Way For Novel Anti-Cancer Therapies

$12M AWARED TO STUDY RADIATION THERAPY AND IMMUNE SIGNALING

With Additions, Commitment Bolstered to Investing in Innovation

Anna Turetsky joins as Venture Investments Principal and Paul Pospisil joins Board The Mark Foundation for Cancer Research (MFCR) announced today the appointment of Anna Turetsky, PhD as Principal, Venture Investments. Turetsky joins MFCR with 10 years of experience in scientific research, consulting, and venture capital. She will work with MFCR’s executive and scientific leadership … Continued

Funding Announced for Eight Projects at the Intersection of Artificial Intelligence and Cancer Research

$2.2 million awarded to harness revolutions in machine learning for cancer research Can 3D renderings of pancreatic cancer tumors provide insights that improve the prognosis for one of the deadliest cancer types? Can machine learning help us better predict which patients will benefit from immunotherapies, which currently have a 30-50 percent success rate? And can … Continued

Funding Announced for the EXTOL Project

Expanding Therapeutic Options for Lung Cancer Patients The Mark Foundation for Cancer Research funds research in memory of personalized medicine pioneer Dr. Waun Ki Hong The Mark Foundation has awarded a three-year $6 million grant to support a new phase of discovery for a team of investigators developing, optimizing, and integrating targeted therapies and immunotherapies … Continued

New Blood Cancer Discoveries Grant Program Launched

The Leukemia & Lymphoma Society (LLS), The Mark Foundation for Cancer Research (MFCR), and The Paul G. Allen Frontiers Group (PAFG) are proud to announce the Blood Cancer Discoveries Grant Program (BCDG), a new grant program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood … Continued